Singapore markets closed
BANKS

DBS CEO says tough for digital banks to muscle into Singapore

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.32-0.37 (-5.53%)
At close: 04:00PM EST
6.37 +0.05 (+0.79%)
After hours: 07:57PM EST
Sign in to post a message.
  • J
    John
    I'm not a scientist nor do I have any specialized education but; if Vaxart has positive P2 results - would that alone prove the VAAST platform works? Regardless of our vaccines actual efficacy, wouldn't the pill platform be proven? It could have 100% efficacy or 40% efficacy - only the vaccine would need more development, not VAAST. Am I correct in thinking this way?
  • f
    fricion
    A little more analysis about the Omicron Variant. The recent market turmoil caused by the emergence of the omicron virus strain may offer investors a chance to position for a trend reversal in reopening and commodity trades, according to JPMorgan Chase & Co.

    While it is likely that omicron is more transmissible, early reports suggest it may also be less deadly, which would fit into the pattern of virus evolution observed historically, strategists Marko Kolanovic and Bram Kaplan wrote in a note Wednesday. This might ultimately be a positive for risk markets because it could signal that the end of the pandemic is in sight, they said.

    “Omicron could be a catalyst for steepening (not flattening) the yield curve, rotation from growth to value, selloff in Covid and lockdown beneficiaries and rally in reopening themes,” the strategists said. “We view the recent selloff in these segments as an opportunity to buy the dip in cyclicals, commodities and reopening themes, and to position for higher bond yields and steepening.”

    The emergence of the new virus strain has roiled markets in recent days, with countries around the world stepping up travel restrictions. While some health officials said it could take weeks to reach a verdict, Australia’s Chief Medical Officer Paul Kelly said there is no indication that it is more deadly than other strains.

    Kolanovic, who became JPMorgan’s chief global markets strategist earlier this year, has advocated reopening trades and defended value stocks as the pandemic has evolved. He has also argued that markets overreacted to the threat of the delta variant.

    It would fit with historical patterns for a less severe and more transmissible virus to quickly crowd out more severe variants, which could turn omicron into a catalyst to transform a deadly pandemic into something more akin to seasonal flu, the JPMorgan strategists wrote in the Wednesday note.
    “If that scenario were to happen, instead of skipping two letters and naming it omicron, the WHO could have skipped all the way to omega,” -- the last letter of the Greek alphabet -- the strategists said.
  • L
    Lyle
    The lawsuit has been resolved;

    "III. CONCLUSION
    For the foregoing reasons, the motions to dismiss by the Vaxart Defendants
    and the Armistice Defendants are granted as to Counts I, IV and V. The court
    requests supplemental briefing and submission of documents cited in the Complaint,
    which will be detailed in a separate letter to the parties. It is so ordered."
  • G
    George
    Apparently some on this board think if you buy 20 shares of a stock thats the entire trade. no thats YOUR entire trade. every block sale is a minimum of 100 shares (Thats why you never see anything on the daily trader of less than 100)
    How is this done? When you ask your broker to buy you 20 shares of stock he says you bet. and then pools your 20 shares with 1 2 or even 10 other people buying to get that 100 block. Thats why when you make a trade ATM the broker usually says something to the effect of "Let me lock in that trade for you and get you a direct confirmation"
    Now. WHen you use robin hood. Your purchases are NOT ATM, you are buying from Robinhood. Who usually owns enough shares to TRANSFER them to you usually at a penny more than the actual market price.
    IF they dont have them they talk to a third party broker and get them. and then transfer them to you (Thats why if your a webull, krakken, robin hood trader... NO mater what you set your sell limits at.... I can still borrow you shares... Because you dont actually have them, robinhood, webull, or krakken does. and they get paid a percentage by me to borrow your shares.

    THis is why Davids claim of 17 of first 20 trades at open today being 100 shares are clearly short sellers... is likely incorrect. and more likely that Retailers with less than 100 shares, are dumping in fear.
  • S
    Saul Goodman
    SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) has entered into an agreement with Kindred Bioscience, Inc. (“KindredBio”) for the purchase of KindredBio’s manufacturing equipment and sublease of its GMP (Good Manufacturing Practices) manufacturing facility in Burlingame, California, giving Vaxart control of its second GMP manufacturing facility.
    The transaction closed Tuesday, Nov. 30, 2021, and Vaxart expects the facility to be operational for GMP production in Q1 2022.

    “This acquisition gives us greater flexibility to manage our manufacturing needs by allowing Vaxart to exercise more control over our quality control program and the timing of our manufacturing activities,” said Andrei Floroiu, Vaxart’s Chief Executive Officer.
  • C
    CHARLES
    “This acquisition gives us greater flexibility to manage our manufacturing needs by allowing Vaxart to exercise more control over our quality control program and the timing of our manufacturing activities,” said Andrei Floroiu, Vaxart’s Chief Executive Officer.
    “Vaxart is developing not only COVID-19 oral tablet and norovirus vaccines but also oral tablet vaccines for other diseases using our proprietary delivery platform. With this second plant, we expect to have the clinical-scale manufacturing capacity necessary to rapidly develop our multiple programs in parallel
  • E
    End2War
    Wondering if they have acquired manufacturing facility in preparation for seeking FDA approval of possible emergency use authorization to sell their vaccine once they have adequate data. Having the proper manufacturing in place is an FDA requirement, and perhaps they are trying to get the manufacturing piece of the application in order for required FDA inspection. Does this make sense?
  • J
    James
    Vaxart has been working on a pill vsccines long before covid ,there is a need for their technology.There are many people that do not like needles the market is very large .
  • B
    Bob
    You don't just simply invest in manufacturing facilities unless there is a solid ROI projected...
  • J
    Junk
    Read the judgment, lawsuit isn't settled yet. I would have preferred that Armistice pay for their tricks (counts IV and V in the suit) but it seems they managed to convince Vaxart directors to take the fall. Key points (counts II and III about directors' unjust enrichment and failure to disclose OWS funding) against the directors are pending more info.

    I honestly don't care about the suit unless Vaxart has to pay for the bad publicity. The directors are just there to enrich themselves so they deserve to lose. The whole company relies on Sean Tucker, everyone else is disposable.
  • G
    George
    @David Disano I dont own a single share of SRNE never have.

    But i do know that you said you were up $20,000 when vaxart was at 9.75 basic math says that means youre average is 8.75 . Remember when i copy and pasted your post because you said you never said it? and then low and behold you went back and deleted the comment? This board remembers. That means as of right now. You not only gave back your 20 k profit, but now youre out an additional 40 grand of your own money. I know youre not worried because you dont ACTUALLY have 20 K shares.

    Remember on WKHS you claimed to buy at 20 and claimed to be buying the gift all the way down to 10 (When i came in and shorted it and made 30 grand in 3 weeks) youre down at LEAST 50% in the red on that one.

    TRME remember you said you were averaged at 2.85? Whats it at right now a buck 60?

    See david, I do this thing called "Paying attention" You clearly dont becasue you still think Ive ever bought SRNE (Thats ohioken BTW, and i think CLarissaTV)
    I also do a completely foreign concept to you called "Making Money" Money in my pocket right now. Not ifs.. and gonnas. and youll sees... money right now in my pocket, and I've made more than youve lied about.
  • C
    Cheri
    You don't just simply invest in manufacturing facilities unless there is a solid ROI projected...
  • N
    NotThatRussell
    This stock is going to continue getting swing traded and shorted until they produce a viable product ie the pill vaccine they’ve promised. If they are able to do that this will fly to the moon like a rocket
  • J
    JDub
    How is it that exactly 35 people dislike Raj's posts. Sometimes I wonder if I am talking to real people here...
  • f
    fricion
    Omicron is a Variant of Concern, promoted by the Fraudsters. The Pandemic is transforming to an endemic in the US and now it is time to help the rest of the World with Mucosal based Covid -19 Pills, and to help ourselves to reduce the threat to ourselves. There are many more viral threats that Vaxart's VAAST Platform can focus on with the help of Investors and World Wide Vaccine Organizations. VXRT is a very Strong Buy below $10.00. Take care all.
  • G
    God Bless America
    Producing a Covid vaccine as a pill is not an easy task. This URL talks about Merck's experience with it: https://greekreporter.com/2021/11/27/merck-pill-less-effective/. Only 30% efficiency. I am saying this to say that Vaxart is on the right pass, albeit I wish they are little faster and more knowledge sharing. I have been holding this stock for almost 2 years, and made good money on it. My belief is that they don't have enough funding to get this to the finish line. Personally, I am not running out of patience.
    Merck said on Friday that its anti-Covid pill was found to be 20% less effective in a final analysis of a clinical trial.
    Merck said on Friday that its anti-Covid pill was found to be 20% less effective in a final analysis of a clinical trial.
    greekreporter.com
  • e
    edf
    the positive announcement isnt getting a positive responses because investors don't trust management...the run up is coming once people see why management is positioning itself...more news is coming to provide a clear explaination of why they are getting set to produce/manufacture product...the real news will be about Buy out...Jnj will soon pop up with investment money from the newly spun off Jnj...no one is talking about the 90 day option Jnj has had on vxrt which was to exercise within 90 days after the start of phase 2
  • C
    CHARLES
    Vaxart Announces Acquisition of Second GMP Manufacturing Facility
    December 1, 2021 at 8:00 AM EST
  • m
    michael
    In the last week or 2 bios are taken out to the wood shed and trashed. XBI and many bio stocks indicate oversold... but why all of a sudden is the whole sector in such big disfavor. Rotation? and what would it take to bring it back? Any insights welcomed.
  • m
    michael
    I am no PR expert but if big pharma can say" we should have an omicron vaccine by March, etc, etc " (when in actuality it is a therapeutic in character) why cant VXRT start a PR campaign discussing the merit of VAAST and how they may have a real vaccine by end of 2022... (if they seriously go after it)...